Research dossier
Clinical research on Glycine
10 trials reviewed across 5 indications.
Strongest evidence
Sleep quality
Mechanism
Glycine is an inhibitory neurotransmitter and acts on NMDA receptors in the suprachiasmatic nucleus, promoting peripheral vasodilation that lowers core body temperature — a physiological cue for sleep onset. The polysomnography data (Yamadera 2007) show faster sleep onset and faster entry to slow-wave sleep.
3 g before bed improved subjective sleep quality and next-day alertness across three small trials, with one showing objective polysomnographic changes. The most-cited use case for glycine — but the entire evidence base is roughly three dozen subjects, all from trials with Ajinomoto involvement.
Studied in adults with mild sleep complaints, not diagnosed insomnia. Effects are modest and the trials are tiny and industry-linked. Not a substitute for a prescription sleep aid in clinical insomnia.
Trials cited
Glycine before bedtime — subjective sleep quality
positive · RCT
Inagawa et al., 2006, Sleep and Biological Rhythmsn=19Industry-fundedDouble-blind crossover trial. 3 g glycine before bed improved self-reported fatigue, liveliness, and clear-headedness the next morning versus placebo. The first of the glycine sleep trials and the basis for the popular '3 g before bed' protocol.
Tiny sample, single-night exposure, entirely subjective endpoints. Authors are affiliated with Ajinomoto, a glycine manufacturer.
Glycine and polysomnographic sleep changes
positive · RCT
Yamadera et al., 2007, Sleep and Biological Rhythmsn=11Industry-fundedSingle-blind crossover with objective polysomnography. 3 g glycine shortened time to fall asleep and time to slow-wave sleep, improved sleep efficiency, and reduced next-day sleepiness — without altering overall sleep architecture. The strongest mechanistic data point for glycine and sleep.
Only 11 subjects and single-blind. Several authors are Ajinomoto-affiliated.
Glycine and daytime performance after sleep restriction
positive · RCT
Bannai et al., 2012, Frontiers in Neurologyn=7Industry-fundedIn deliberately sleep-restricted healthy men, 3 g glycine before bed reduced next-day fatigue and improved psychomotor vigilance reaction times versus placebo. Glycine did not change plasma melatonin.
Only 7 subjects, single-blind, all-male. Conducted by Ajinomoto's Frontier Research Labs — every author was a company employee.
Glutathione, oxidative stress & healthy aging (GlyNAC)
Mechanism
Glycine is one of three amino acids in glutathione, the body's master antioxidant. Pairing it with NAC (a cysteine donor) supplies both rate-limiting substrates, which is the rationale for raising glutathione and reducing oxidative stress with aging.
The GlyNAC anti-aging story comes from Sekhar's Baylor group. The 24-week pilot (n=8, uncontrolled) reported broad improvements; the larger placebo-controlled trial (n=114) did NOT raise glutathione in the overall population, only in a post-hoc high-stress subgroup. Promising hypothesis, not yet confirmed.
All data combine glycine WITH NAC, so glycine's solo effect is unknown. The single controlled trial was effectively null on its primary endpoint. Do not present GlyNAC as established anti-aging therapy.
GlyNAC (glycine + NAC) pilot in older adults
positive · Pilot
Kumar et al., 2021, Clinical and Translational Medicinen=8Sekhar's Baylor group reported that 24 weeks of GlyNAC corrected glutathione deficiency and improved markers of oxidative stress, mitochondrial function, insulin resistance, muscle strength, gait speed, and cognition in older adults — with several gains reversing after washout.
Only 8 subjects and no parallel placebo group — an uncontrolled single-arm pilot. Combines glycine with NAC, so glycine's independent contribution cannot be isolated. A larger, independent placebo-controlled trial (Lizzo 2022) did not replicate the glutathione effect in the general study population.
GlyNAC randomized controlled trial — glutathione status
Null · RCT
Lizzo et al., 2022, Frontiers in Agingn=114Industry-fundedAn independent, properly placebo-controlled GlyNAC trial (run by the Nestlé Institute, separate from Sekhar's group). Across the full study population, GlyNAC did not raise total glutathione or the reduced:oxidized ratio versus placebo at any dose. Only a post-hoc subgroup with high baseline oxidative stress and low glutathione showed a modest increase.
Short 2-week duration (vs 24 weeks in the pilot) limits comparison. But as the only independent, placebo-controlled GlyNAC trial, its null primary endpoint is the honest counterweight to the single-group pilot headlines. Post-hoc subgroup findings are hypothesis-generating, not confirmatory.
Metabolic syndrome & blood pressure
Mechanism
Glycine has anti-inflammatory and antioxidant actions and may improve endothelial function; observationally, low circulating glycine tracks with insulin resistance and type 2 diabetes.
One 60-person RCT found that 15 g/day for 3 months lowered systolic blood pressure and oxidative-stress markers in metabolic syndrome — but did not move fasting insulin or core glycemic measures. A single, unreplicated trial at a high dose.
Relevant to people who already have metabolic syndrome, not the general population. The favorable signal is on blood pressure and oxidative stress, not blood glucose. Needs replication before any clinical recommendation.
Oral glycine in metabolic syndrome
mixed · RCT
Díaz-Flores et al., 2013, Canadian Journal of Physiology and Pharmacologyn=60Double-blind, placebo-controlled. 15 g/day glycine for 3 months raised antioxidant enzyme activity, lowered lipid peroxidation, and reduced systolic blood pressure in metabolic syndrome patients. It did not significantly change fasting insulin or the core glycemic measures.
Single trial, 60 participants, high 15 g/day dose. Antioxidant and SBP benefits are encouraging but unreplicated; the glucose/insulin story was essentially flat.
Schizophrenia negative symptoms (adjunct)
Mechanism
Glycine is an obligatory co-agonist at the NMDA receptor. The glutamate hypothesis of schizophrenia predicts that boosting NMDA co-agonism (with ~40–60 g/day glycine) could ease negative symptoms.
Small early trials (Heresco-Levy 1999) showed ~30% reductions in negative symptoms, but the larger multi-site CONSIST trial (n=157) found no benefit, and glycine added to clozapine was null. A specialist, high-dose psychiatric application with mixed results — not a consumer supplement use.
High-dose (≈40–60 g/day) adjunctive use under psychiatric supervision only. The well-powered trial was negative. This is included for completeness, not as a self-care recommendation.
High-dose glycine for schizophrenia negative symptoms
positive · RCT
Heresco-Levy et al., 1999, Archives of General Psychiatryn=22Double-blind, placebo-controlled crossover in 22 patients. Adjunctive high-dose glycine produced a ~30% reduction in negative symptoms (PANSS) and improved BPRS scores. Glycine acts as an NMDA-receptor co-agonist; low baseline serum glycine predicted response.
Specialist, high-dose (≈40–60 g/day) adjunctive psychiatric use — not a consumer supplement context. Small and not replicated in larger trials (see CONSIST).
CONSIST — glutamatergic agents for schizophrenia
Null · RCT
Buchanan et al., 2007, American Journal of Psychiatryn=157The larger, multi-site CONSIST trial found no difference between adjunctive glycine and placebo on negative symptoms or cognition. This well-powered negative result substantially tempers the earlier small positive glycine schizophrenia trials.
Some patients in CONSIST were on clozapine, which may interfere with glycine-site agonism — but the overall result was firmly null.
Glycine added to clozapine
Null · RCT
Evins et al., 2000, American Journal of Psychiatryn=30Double-blind, placebo-controlled. Adding high-dose glycine to clozapine produced no improvement in positive, negative, or cognitive symptoms — and signaled that glycine-site agonists may be ineffective specifically when combined with clozapine. This is the basis for the documented glycine–clozapine interaction caution.
Psychiatric, high-dose adjunctive context. The relevance to consumer dosing is the interaction signal, not the efficacy question.
Collagen & connective tissue (mechanistic)
Mechanism
Glycine makes up roughly one-third of collagen's amino-acid residues. A metabolic-flux analysis argues endogenous synthesis plus diet falls ~10 g/day short of full demand, making glycine 'conditionally essential' for collagen.
Glycine is structurally central to collagen, and there's a credible argument that most people are mildly short of it. But that is a biochemistry argument — no human RCT has shown that supplementing glycine improves skin, joints, or wound healing. Mechanism-only.
No clinical outcome trials. If the goal is collagen-dependent skin or joint support, hydrolyzed collagen peptides have far more direct RCT evidence than isolated glycine.
Glycine biosynthesis vs collagen demand
mixed · Observational
Meléndez-Hevia et al., 2009, Journal of BiosciencesA widely-cited metabolic analysis arguing that endogenous glycine synthesis (~3 g/day from serine) plus typical dietary intake falls roughly 10 g/day short of total metabolic demand — making glycine 'conditionally essential.' Glycine is ~⅓ of collagen by residue. This is the mechanistic case for supplementing glycine for connective tissue.
A flux/stoichiometry argument, not a clinical trial. No skin, joint, or wound-healing RCT has shown that glycine supplementation improves collagen-dependent outcomes in humans. Treat as plausible mechanism, not proven benefit.
2 forms of Glycine compared
Glycine (free-form, powder or capsule)
Well absorbed
Best forSleep (3 g before bed), glutathione/GlyNAC stacks, collagen substrateNaturally sweet-tasting powder, which makes the 3 g sleep dose easy to take in water. The free amino acid is the form used in essentially every glycine clinical trial; there is no premium 'branded' form for glycine itself.
Magnesium glycinate (bisglycinate)
Well absorbed
Best forDelivers glycine bound to magnesium; popular for sleep and calmA common way people consume glycine without realizing it. The glycine fraction per dose is modest compared with a dedicated 3 g glycine serving, so don't count magnesium glycinate as a full glycine dose for sleep.
Are you deficient? Symptoms, risk groups, lab tests
Glycine is conditionally essential — the body synthesizes it from serine, but a widely-cited metabolic analysis estimates endogenous production plus diet falls roughly 10 g/day short of full demand in a 70 kg adult. Frank deficiency is rare; relative insufficiency for collagen synthesis may be common.
Common symptoms
- There is no defined clinical 'glycine deficiency syndrome' in healthy adults
- Theorized relative shortfall affects collagen-heavy tissues (skin, joints, connective tissue) rather than producing acute symptoms
- Low circulating glycine is observed alongside insulin resistance and type 2 diabetes (association, not proven cause)
Who is at risk
Older adults
Glutathione synthesis and glycine availability decline with age — the rationale behind the GlyNAC aging research, though benefit remains unproven in controlled trials.
People with very low protein or collagen intake
Dietary glycine comes largely from collagen-rich tissues (skin, bone, connective tissue) that modern diets under-consume, widening the gap between synthesis and demand.
People with metabolic syndrome or type 2 diabetes
Lower plasma glycine is consistently observed in insulin-resistant states; whether this is cause or consequence is unresolved.
Side effects and drug interactions
Side effects
GI upset (nausea, soft stools, stomach discomfort)
Uncommon · Uncommon at 3 g; more likely above ~15 g/day
Glycine is a dietary amino acid and very well tolerated at the 3 g sleep dose. GI complaints appear mainly at the much higher doses used in metabolic (15 g) and psychiatric (40–60 g) studies.
Worse with:glycine
Mild drowsiness
Uncommon
Consistent with glycine's calming, sleep-promoting action when taken before bed. Generally the intended effect rather than an adverse one.
Drug interactions
Reduces nutrient status
clozapineGlycine appears to blunt clozapine's antipsychotic efficacy — adding glycine to clozapine produced no symptom benefit, and glycine-site agonists are thought to be less effective specifically alongside clozapine (Evins 2000).
If you take clozapine, do not start glycine supplementation without consulting your prescriber.
Other
antipsychotics (general)NMDA-modulating psychiatric agentsGlycine is an NMDA-receptor co-agonist; high doses can modulate glutamatergic signaling relevant to psychiatric treatment.
High-dose glycine in anyone on psychiatric medication should be supervised by the prescribing clinician. Typical 3 g sleep doses are far below the psychiatric range.
Other critical caveats
- Glycine on clozapine can blunt the antipsychotic's effect — never combine without your prescriber's guidance.
- Every published glycine sleep trial is small (7–19 subjects) and involves Ajinomoto, a glycine manufacturer. The sleep benefit is plausible and consistently directionally positive, but the evidence base is thin and not independent.
- The GlyNAC anti-aging headlines come from one tiny uncontrolled pilot. The larger placebo-controlled trial did NOT raise glutathione in the overall population. Treat GlyNAC as a promising hypothesis, not proven therapy.
- Glycine is central to collagen biochemistry, but no human RCT shows that supplementing it improves skin, joint, or connective-tissue outcomes. The collagen claim is mechanism-only.
Frequently asked
Does glycine actually help you sleep?
Probably modestly. Three small trials (a combined ~37 subjects) found that 3 g of glycine before bed improved self-reported sleep quality and next-day alertness, and one used polysomnography to show faster sleep onset. The catch: every one of those trials involved Ajinomoto, a glycine manufacturer, and none enrolled people with diagnosed insomnia. It's a low-risk thing to try, but the evidence is thin and not independent.How much glycine should I take for sleep?
The studied dose is 3 g (about one teaspoon of powder) taken roughly 30–60 minutes before bed. Glycine is naturally sweet, so it mixes easily into water. Higher doses haven't been shown to work better for sleep.Is GlyNAC proven for anti-aging?
No. The exciting GlyNAC results come from a single 24-week pilot in just 8 older adults with no placebo group. When the same research group ran a larger, properly placebo-controlled trial, GlyNAC did not raise glutathione in the overall study population — only in a post-hoc subgroup. It's a genuinely interesting hypothesis, but it has not been confirmed.Glycine is in collagen — does taking it help skin and joints?
Glycine is about one-third of collagen by amino-acid content, and there's a reasonable argument that most people are slightly short of it. But no human trial has shown that supplementing isolated glycine improves skin or joints. For collagen-related goals, hydrolyzed collagen peptides have far more direct clinical evidence.Is glycine safe?
For a healthy adult, yes — it's a dietary amino acid and the 3 g sleep dose is very well tolerated. GI upset becomes more likely at the much higher doses (15 g and up) used in metabolic and psychiatric research. The one real caution: if you take clozapine, glycine may reduce its effect, so clear it with your prescriber first.
References
- 01Examine.com — Glycine
- 02PubChem — Glycine (NIH/NCBI)
- 03Meléndez-Hevia et al., 2009 — Glycine biosynthesis vs collagen demand (PubMed)
- 04Kumar et al., 2021 — GlyNAC pilot in older adults (PubMed)
Last reviewed2026-05-24